© 2003 BMJ Publishing Group, British Association for Accident & Emergency Medicine, & Faculty of Accident & Emergency Medicine
REVIEW
Role of fibrin D-dimer testing in emergency medicine
1 Department of Emergency Medicine, Beaumont Hospital, Dublin, Republic of Ireland
2 Department of Surgery, Beaumont Hospital
Correspondence to:
Correspondence to:
Dr A Wakai, Department of Emergency Medicine, Beaumont Hospital, Dublin 9, Ireland;
wakai{at}indigo.ie
Objectives: Systemic values of the fibrinolytic plasma marker fibrin D-dimer are raised in a variety of acute clinical conditions. D-dimer values can now be rapidly determined and used to aid diagnosis in emergency medicine. However, despite clinical guidelines, inappropriate and unnecessary measurement of D-dimer values is a significant clinical problem. An understanding of the pathophysiological basis and limitations of the value of D-dimer values may help reduce this problem. This review discusses the pathophysiology of the fibrinolytic system. The currently used assays, clinical indications, and limitations of D-dimer measurement are reviewed. Finally, the potential future clinical indications for measurement of D-dimer values in emergency medicine are discussed.
Methods: Literature on D-dimer was identified from Medline, along with cross referencing from the reference lists of major articles on the subject
Results and conclusions: Systemic D-dimer values aids diagnosis, and is potentially a prognostic indicator, in a variety of clinical conditions in emergency medicine. However, it has limited specificity in patients with comorbid conditions. Although, currently, there is no standard D-dimer assay, immunoturbidimetric assays are the most suitable for use in emergency medicine
Keywords: D-dimer
Abbreviations: DD, D-dimer; VTE, venous thromboembolism; tPA, tissue plasminogen activator; XL-Fg, crosslinked fibrin; FDP, fibrin degradation product; ELISA, enzyme linked immunosorbent assay; HMW, high molecular weight; LMW, low molecular weight; FACT, Fibrin Assay Comparison Trial; CT, computed tomography; PE, pulmonary embolism; DVT, deep vein thrombosis; PTP, pretest probability; CHD, coronary heart disease; ACS, acute coronary syndrome; MI, myocardial infarction
Relevant Article
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Emerg. Med. J. 2003 20: 303.
This article has been cited by other articles:
-
Guo, M., Daines, D., Tang, J., Shen, Q., Perrin, R. M., Takada, Y., Yuan, S. Y., Wu, M. H.
(2009). Fibrinogen-{gamma} C-Terminal Fragments Induce Endothelial Barrier Dysfunction and Microvascular Leak via Integrin-Mediated and RhoA-Dependent Mechanism. Arterioscler. Thromb. Vasc. Bio.
29: 394-400
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
